Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
D000328:Adult; D000368:Aged; D001321:Autistic Disorder; D001519:Behavior; D001593:Benzyl Compounds / Q000627:therapeutic use; D002389:Catatonia / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D002908:Chronic Disease; D003071:Cognition; D005116:Extrapyramidal Tracts; D005260:Female; D006760:Hospitalization; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000009:adverse effects / Q000627:therapeutic use; D007273:Injections, Intramuscular; D008875:Middle Aged; D009043:Motor Activity; D009069:Movement Disorders / Q000139:chemically induced; D010276:Parasympatholytics / Q000627:therapeutic use; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders; D011728:Pyridones / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D012919:Social Behavior; D013141:Spiro Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013237:Stereoisomerism; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001593:Benzyl Compounds; D006846:Hydrocarbons, Halogenated; D010276:Parasympatholytics; D010880:Piperidines; D011728:Pyridones; D013141:Spiro Compounds; D014149:Tranquilizing Agents